Erythropoietin and Protection of Renal Function in Cardiac Surgery (the EPRICS Trial).

Alain Dardashti, Per Ederoth, Lars Algotsson, Björn Brondén, Edgars Grins, Mårten Larsson, Shahab Nozohoor, Galyna Zinko, Henrik Bjursten

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

33 Citeringar (SciVal)

Sammanfattning

To date, there are no known methods for preventing acute kidney injury after cardiac surgery. Increasing evidence suggests that erythropoietin has renal antiapoptotic and tissue protective effects. However, recent human studies have shown conflicting results. The authors aimed to study the effect of a single high-dose erythropoietin preoperatively on renal function after coronary artery bypass grafting in patients with preoperative impaired renal function.
Originalspråkengelska
Sidor (från-till)582-590
TidskriftAnesthesiology
Volym121
Utgåva3
DOI
StatusPublished - 2014

Ämnesklassifikation (UKÄ)

  • Anestesi och intensivvård

Fingeravtryck

Utforska forskningsämnen för ”Erythropoietin and Protection of Renal Function in Cardiac Surgery (the EPRICS Trial).”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här